GCP
VIRX

GSA Capital Partners’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

GSA Capital Partners’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-26,184
Closed -$182K – 1565
2020
Q4 		$182K Buy
26,184
+16,825
+180% +$117K 0.03% 1018
2020
Q3 		$41K Buy
+9,359
New +$41K 0.01% 1193